Connecticut Innovations (CI) invested $43.2 million in about 100 Connecticut companies during the recently concluded fiscal year, the quasi-public venture capital agency reported this week.
That represented a nearly 10% increase over CI’s equity investments during the prior fiscal year, which totaled $39.4 million.
“Following another active year of investment and engagement, CI continues to add to its portfolio of exciting, high-potential companies,” David Wurzer, chief investment officer and executive vice president, said in a statement. “Even in this challenging climate, we continue to see substantial progress being made and milestones achieved by many of our portfolio companies across a broad range of technology categories. We look forward to supporting their growth in the coming year.”
The lion’s share went to bioscience and healthcare companies ($25.8 million) and information technology companies ($15.9 million). In Hartford County, 21 companies received a combined $8.6 million, according to CI data.
CI said its transactions during the year leveraged an additional $436 million in outside capital.
Here are CI’s largest fiscal year 2020 investments, which included transactions with new and existing portfolio companies alike:
- Rallybio, New Haven, $2.6 million
- LogicSource, South Norwalk, $2.5 million
- American Customer Care, Bristol, $1.5 million
- Biowave Corp., Norwalk, $1.5 million
- Covr Financial Technologies, Hartford, $1.5 million
- Point Pickup, Greenwich, $1.5 million
- IsoPlexis, Branford, $1.5 million
